Abstract 1048: Genomic analysis of patients with relapsed ovarian cancer enrolled in a phase II trial of nivolumab and bevacizumab
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3081886009
